Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Xeris Pharmaceuticals Inc (XERS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Xeris Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.740 -0.020    -1.14%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
1.730
-0.010
-0.575%
18:56:43 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,999,411
  • Bid/Ask: 1.730 / 1.770
  • Day's Range: 1.690 - 1.780
Xeris Pharmaceuticals 1.740 -0.020 -1.14%

XERS Income Statement

 
Featured here, the Income Statement (earnings report) for Xeris Pharmaceuticals Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 44.39 48.32 38.01 33.2
Revenue 44.39 48.32 38.01 33.2
Other Revenue, Total - - - -
Cost of Revenue, Total 7.57 8.2 7.56 5.32
Gross Profit 36.82 40.12 30.45 27.88
Total Operating Expenses 54.23 53.23 53.99 46.47
Selling/General/Admin. Expenses, Total 37.57 37.29 37.64 33.6
Research & Development 6.38 5.03 6.09 4.84
Depreciation / Amortization -0.054 0.091 -0.014 -0.036
Interest Expense (Income) - Net Operating -7.02 -6.85 -6.53 -6.22
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 9.78 9.47 9.25 8.96
Operating Income -9.84 -4.91 -15.98 -13.28
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 0.146 - - -
Other, Net 3.64 7.61 4.54 3.56
Net Income Before Taxes -13.63 -12.53 -20.52 -16.83
Provision for Income Taxes -0.236 -0.338 -0.675 -
Net Income After Taxes -13.39 -12.19 -19.84 -16.83
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -13.39 -12.19 -19.84 -16.83
Total Extraordinary Items - - - -
Net Income -13.39 -12.19 -19.84 -16.83
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -13.39 -12.19 -19.84 -16.83
Dilution Adjustment - - - -
Diluted Net Income -13.39 -12.19 -19.84 -16.83
Diluted Weighted Average Shares 138.12 138.06 137.34 137.14
Diluted EPS Excluding Extraordinary Items -0.097 -0.088 -0.144 -0.123
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.072 -0.048 -0.097 -0.083
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

XERS Comments

Write your thoughts about Xeris Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Anestis Koulis
Anestis Koulis Jul 20, 2022 2:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone think we re gonna see 1.75 soon ?
James Griffith
James Griffith Jan 05, 2022 5:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Another Red day. It's great to buy at these low prices. I just hope it will recover before I run out of money or own it.
James Griffith
James Griffith Jan 05, 2022 12:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Patience is key when investing here. Huge shorting, and FUD it's enough to create doubt. Just remember to DD and you will feel better about your decision
Mike Rich
Mike Rich Jan 02, 2022 5:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I've been researching this Company all day. Investing now. Here's a link to some info if you're interested.https://1drv.ms/f/s!AtO4hLISyqu2gqAeKyTh59EUVDBCrw
Najmuddin Jabalpurwala
Najmuddin Jabalpurwala Jan 02, 2022 5:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great research. thanks for sharing. I have been buying this stock from $1.9 price onwards. while the company seems to be generating all the right news, we are yet to see all these FDA approvals convert into Revenue and Profits. Hoping 2022 to be the year for that.
Najmuddin Jabalpurwala
Najmuddin Jabalpurwala Jan 02, 2022 5:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great research. thanks for sharing. I have been buying this stock from $1.9 price onwards. while the company seems to be generating all the right news, we are yet to see all these FDA approvals convert into Revenue and Profits. Hoping 2022 to be the year for that.
сергей иванов
сергей иванов Dec 29, 2021 6:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought 44444 at 2.57. Teik proffit - 7.99
Mirchu Malik
Mirchu Malik Aug 12, 2021 4:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I need bitcoin any one have
the elrushbo
theelrushbo Aug 11, 2021 4:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/news/3729101-xeris-shares-surge-12-on-fda-greenlight-for-levothyroxine-hypothyroidism-study
Haqi Hamdi
Haqi Hamdi May 27, 2021 9:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any update about this stock
justone txaggie
justone txaggie Apr 13, 2021 8:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Only going down. Such a disappointment
Manos Tsigrimanis
Manos Tsigrimanis Mar 11, 2021 4:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello to all. I had stocks of Xers a long time ago and I am back to get some now. I saw the earning. What are we waiting regarding the future if someone can summarize. Thanks in advanced
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email